CEACAM5 and leukocyte adhesion deficiency: CEA, a biomarker for LAD diagnosis 22, was enhanced in the serum of patients with LAD (Fig. 8F), and there was a positive correlation between serum CEA and serum Exo-circRAPGEF5 expression in LAD (Fig. 8G).